2026 FDA Peptide Reclassification Purefico Medspa and Therapy When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest BPC 157: The Body Protection Compound Revolutionizing Regenerative Medicine 503Pharma The internet says BPC 157 is banned the FDA says something more nuanced. At Moonshot Medical in Park Ridge, IL, we provide honest, current guidance on peptide therapy through licensed compounding pharmacies.